Ozempic may have revealed the brain’s hidden “craving center”
Wednesday, August 12, 2026Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.
Ozempic-like drugs appear to weaken more than hunger—they may also reduce cravings for alcohol and other addictive substances. Scientists are increasingly tracing this effect to the lateral septum, a brain region that helps connect memories and surroundings with rewarding experiences. Packed with GLP-1 receptors, it may act as a crucial control point between thinking about a reward and feeling compelled to pursue it. The discovery could open new approaches to treating addiction as well as obesity. (via Science Daily)
Read the Full StoryThis article will expire in 10 days.
In the News...
View All Recent News
- Your waist size may reveal health risks BMI misses
- One injection could keep osteoarthritis drugs working for weeks
- Scientists challenge a 70-year-old “lizard brain” myth
- Popular sweeteners may leave effects that last for generations
- Scientists find why the liver may not heal even after you stop drinking
- A cancer therapy put severe rheumatoid arthritis into remission
- Common supplements rival antibiotics for severe gum disease
- Researchers unveil sustainable spirulina solution to vitamin B12 deficiency
- HEPA air purifiers may boost brain function after just one month
- Keto diet cut liver fat by 67% in a clinical trial
- Dogs may hold surprising clues to human longevity
- Long-term melatonin use linked to 90% higher heart failure risk
- Your sleep may be hiding an early clue to Alzheimer’s
- Scientists discover why damaged nerves struggle to heal
- Researchers followed 400,000 kids for 20 years and found a lasting pre-K advantage
- A common vape flavoring may disrupt early embryo development
- Experimental eye drops help blind mice see again
- Scientists tested 212 plant-based meat alternatives. Every one contained fungal toxins
- Scientists discover a brain “brake” that can shut down chronic pain
- Eating more ultra-processed foods may raise prostate cancer risk by 30%